Schreiber RD - Search Results

1

Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.

Nishikawa H, Kato T, Tawara I, Saito K, Ikeda H, Kuribayashi K, Allen PM, Schreiber RD, Sakaguchi S, Old LJ, Shiku H. Nishikawa H, et al. Among authors: schreiber rd. J Exp Med. 2005 Mar 7;201(5):681-6. doi: 10.1084/jem.20041959. J Exp Med. 2005. PMID: 15753203 Free PMC article.

2

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

Dighe AS, Richards E, Old LJ, Schreiber RD. Dighe AS, et al. Among authors: schreiber rd. Immunity. 1994 Sep;1(6):447-56. doi: 10.1016/1074-7613(94)90087-6. Immunity. 1994. PMID: 7895156

3

Immunology at 2000.

Allen PM, Murphy KM, Schreiber RD, Unanue ER. Allen PM, et al. Among authors: schreiber rd. Immunity. 1999 Dec;11(6):649-51. doi: 10.1016/s1074-7613(00)80139-9. Immunity. 1999. PMID: 10626887 Free article. No abstract available.

4

Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, Shiku H, Schreiber RD, Allen PM. Hanson HL, et al. Among authors: schreiber rd. Immunity. 2000 Aug;13(2):265-76. doi: 10.1016/s1074-7613(00)00026-1. Immunity. 2000. PMID: 10981969 Free article.

5

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. Shankaran V, et al. Among authors: schreiber rd. Nature. 2001 Apr 26;410(6832):1107-11. doi: 10.1038/35074122. Nature. 2001. PMID: 11323675

6

The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Ikeda H, Old LJ, Schreiber RD. Ikeda H, et al. Among authors: schreiber rd. Cytokine Growth Factor Rev. 2002 Apr;13(2):95-109. doi: 10.1016/s1359-6101(01)00038-7. Cytokine Growth Factor Rev. 2002. PMID: 11900986 Review.

7

Cancer immunoediting: from immunosurveillance to tumor escape.

Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Nat Immunol. 2002 Nov;3(11):991-8. doi: 10.1038/ni1102-991. Nat Immunol. 2002. PMID: 12407406 Review.

8

The three Es of cancer immunoediting.

Dunn GP, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Annu Rev Immunol. 2004;22:329-60. doi: 10.1146/annurev.immunol.22.012703.104803. Annu Rev Immunol. 2004. PMID: 15032581 Free article. Review.

9

The immunobiology of cancer immunosurveillance and immunoediting.

Dunn GP, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Immunity. 2004 Aug;21(2):137-48. doi: 10.1016/j.immuni.2004.07.017. Immunity. 2004. PMID: 15308095 Free article. Review.

10

IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.

Dunn GP, Sheehan KC, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Cancer Res. 2005 Apr 15;65(8):3447-53. doi: 10.1158/0008-5472.CAN-04-4316. Cancer Res. 2005. PMID: 15833880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters